Literature DB >> 12001500

Vaccination against foot-and-mouth disease: the implications for Canada.

Sarah Kahn1, Dorothy W Geale, Paul R Kitching, Alice Bouffard, Denis G Allard, J Robert Duncan.   

Abstract

Vaccination of susceptible animals against foot-and-mouth disease (FMD) is a well established strategy for helping to combat the disease. Traditionally, FMD vaccine has been used to control a disease incursion in countries where the disease has been endemic rather than in countries considered free of the disease. In 2001, the use of vaccine was considered but not implemented in the United Kingdom (1), whereas vaccine was used to help to control FMD in The Netherlands (2,3). Canadian contingency plans provide for the use of vaccine; Canada is a member of the North American Foot-and-Mouth Disease Vaccine Bank, which could supply vaccine if needed. This article explains why Canada might use FMD vaccine to combat an outbreak and the factors that are relevant to the disposal of vaccinated animals and their products. It concludes that vaccination is an important mechanism in Canada's preparedness for an outbreak of FMD and that products from vaccinated animals are safe for human consumption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12001500      PMCID: PMC339268     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  17 in total

1.  The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine.

Authors:  A Podda
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

Review 2.  Foot-and-mouth disease and beyond: vaccine design, past, present and future.

Authors:  F Brown
Journal:  Arch Virol Suppl       Date:  1999

3.  FMD: chief scientist sets out his views on vaccination.

Authors: 
Journal:  Vet Rec       Date:  2001-09-29       Impact factor: 2.695

4.  Foot-and-Mouth Disease in Man.

Authors:  H Dlugosz
Journal:  Br Med J       Date:  1943-02-13

5.  Differentiating infection from vaccination in foot-and-mouth disease.

Authors:  D K Mackay
Journal:  Vet Q       Date:  1998       Impact factor: 3.320

6.  Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission.

Authors:  J S Salt; P V Barnett; P Dani; L Williams
Journal:  Vaccine       Date:  1998-04       Impact factor: 3.641

7.  International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants.

Authors:  P V Barnett; L Pullen; L Williams; T R Doel
Journal:  Vaccine       Date:  1996-09       Impact factor: 3.641

8.  Evaluation of three 'ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production.

Authors:  A V Iyer; S Ghosh; S N Singh; R A Deshmukh
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

9.  A universal virus inactivant for decontaminating blood and biopharmaceutical products.

Authors:  F Brown; R F Meyer; M Law; E Kramer; J F Newman
Journal:  Dev Biol Stand       Date:  1999

Review 10.  Adjuvants for human vaccines--current status, problems and future prospects.

Authors:  R K Gupta; G R Siber
Journal:  Vaccine       Date:  1995-10       Impact factor: 3.641

View more
  7 in total

1.  In vitro evolution and affinity-maturation with Coliphage qβ display.

Authors:  Claudia Skamel; Stephen G Aller; Alain Bopda Waffo
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

2.  The effect of foot-and-mouth disease (FMD) vaccination on virus transmission and the significance for the field.

Authors:  Karin Orsel; Annemarie Bouma
Journal:  Can Vet J       Date:  2009-10       Impact factor: 1.008

3.  Effect of Foot-and-Mouth Disease Vaccination on Acute Phase Immune Response and Anovulation in Hanwoo (Bos taurus coreanae).

Authors:  Daehyun Kim; Joonho Moon; Jaejung Ha; Doyoon Kim; Junkoo Yi
Journal:  Vaccines (Basel)       Date:  2021-04-22

4.  Modeling the Effects of Multiple Intervention Strategies on Controlling Foot-and-Mouth Disease.

Authors:  Steady Mushayabasa; Gift Tapedzesa
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

5.  Exploiting serological data to understand the epidemiology of foot-and-mouth disease virus serotypes circulating in Libya.

Authors:  Ibrahim Eldaghayes; Abdunaser Dayhum; Abdulwahab Kammon; Monier Sharif; Giancarlo Ferrari; Christianus Bartels; Keith Sumption; Donald P King; Santina Grazioli; Emiliana Brocchi
Journal:  Open Vet J       Date:  2017-01-13

6.  Does Size Matter to Models? Exploring the Effect of Herd Size on Outputs of a Herd-Level Disease Spread Simulator.

Authors:  Mary Van Andel; Tracey Hollings; Richard Bradhurst; Andrew Robinson; Mark Burgman; M Carolyn Gates; Paul Bingham; Tim Carpenter
Journal:  Front Vet Sci       Date:  2018-05-04

7.  Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.

Authors:  Ming Yang; Wanhong Xu; Melissa Goolia; Zhidong Zhang
Journal:  Virol J       Date:  2014-08-01       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.